Xiujie Sun

XiuJie Sun is an accomplished Associate Principal Scientist at Merck, specializing in stromal immunology and autoimmune disease with a focus on small molecules since June 2023. Prior to this role, XiuJie held the position of Lab Leader and Associate Director at Innovent Biologics, where responsibilities included early drug discovery and leading pipeline projects for antibody-drug conjugates and immune-oncology large molecules. Additional experience includes serving as an Immunology Scientist at MaxCyte, Inc., emphasizing cell therapy and CAR-engineered immune cell function, as well as holding senior research roles at The George Washington University and the Shanghai Institutes for Biological Sciences. XiuJie earned a PhD in Biochemistry and Molecular Biology from the Shanghai Institutes for Biological Sciences and a Bachelor's degree in Biotechnology from Zhejiang University.